Home > Insider Trading > Filing (0000950170-25-003432)

Filing Details

Accession Number:: 0000950170-25-003432
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-08 16:05:05
Reporting Period:: 2025-01-07

Accepted Time:: 2025-01-08 16:05:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Revvity Inc.	RVTY	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408107	S Tajinder Vohra	77 4Th Avenue Waltham MA 02451-7567	Please See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-01-07	5,492	$81.29	25,144	No	4	M	Direct
Common Stock	Disposition	2025-01-07	2,430	$116.13	22,714	No	4	S	Direct
Common Stock	Disposition	2025-01-07	2,388	$117.14	20,326	No	4	S	Direct
Common Stock	Disposition	2025-01-07	474	$117.79	19,852	No	4	S	Direct
Common Stock	Disposition	2025-01-07	200	$118.92	19,652	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Acquisiton	2025-01-07	5,492	$0.00	5,492	$81.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-01-30	No	4	M	Direct

Footnotes

The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $118.84 to $119.00. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted.